Literature DB >> 8089070

Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers.

A Bach1, H Böhrer, J Motsch, E Martin, H K Geiss, H G Sonntag.   

Abstract

The use of intravascular catheters is associated with infectious complications. Using plastic materials with antibacterial activity may reduce catheter-related bacterial colonization. A novel intravascular catheter impregnated with the antiseptics silver-sulphadiazine and chlorhexidine was tested in an in-vivo model using implantation of catheters into the internal jugular veins of rats. The rate and magnitude of bacterial colonization in groups with implantation of silver-sulphadiazine and chlorhexidine bonded (SSC) and control (C) catheters were assessed 3 and 7 days after intravenous implantation, and local challenge at the exit site by 10(7) cfu Staphylococcus epidermidis ATCC 35984. Significant reductions in the culture positivity of catheters were observed in the test compared with control groups. After 3 and 7 days, the magnitude of bacterial colonization of implanted catheter segments was significantly lower compared with control catheters (P < 0.01). These findings indicate that antiseptic-bonded catheters substantially reduce the incidence and magnitude of catheter-related bacterial colonization, and may subsequently reduce catheter-related infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089070     DOI: 10.1093/jac/33.5.969

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

Review 1.  Prevention of infections caused by central venous catheters--established and novel measures.

Authors:  A Bach
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents.

Authors:  R K Tcholakian; I I Raad
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  The relationship between methodological trial quality and the effects of impregnated central venous catheters.

Authors:  Christine Geffers; Irina Zuschneid; Tim Eckmanns; Henning Rüden; Petra Gastmeier
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

4.  Microbicidal activity of a new silver-containing polymer, SPI-ARGENT II.

Authors:  G Kampf; B Dietze; C Grosse-Siestrup; C Wendt; H Martiny
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.

Authors:  A Bach
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients.

Authors:  R J Sherertz; S O Heard; I I Raad; L Gentry; D Bowton; P Scuderi; J Hu; W Carruth; B Satishchandra; J Pepe; A Mosenthal; T Burke; J Dupuis
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Analysis of the acute cytotoxicity of the Erlanger silver catheter.

Authors:  J Greil; T Spies; M Böswald; T Bechert; S Lugauer; A Regenfus; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

8.  Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter.

Authors:  M Böswald; S Lugauer; A Regenfus; G G Braun; P Martus; C Geis; J Scharf; T Bechert; J Greil; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

9.  Biodegradable polymer releasing antibiotic developed for drainage catheter of cerebrospinal fluid: in vitro results.

Authors:  Song Yup Han; Soo Han Yoon; Ki Hong Cho; Han Jin Cho; Jeong Ho An; Young Sin Ra
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

10.  Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.

Authors:  Cristóbal León; Sergio Ruiz-Santana; Jordi Rello; Maria V de la Torre; Jordi Vallés; Francisco Alvarez-Lerma; Rafael Sierra; Pedro Saavedra; Francisco Alvarez-Salgado
Journal:  Intensive Care Med       Date:  2004-07-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.